OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms
John H. Krystal, Ege T. Kavalali, Lisa M. Monteggia
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 41-50
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders
Noemi Nicosia, M. Giovenzana, Paulina Misztak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6521-6521
Open Access | Times Cited: 17

Therapeutic mechanisms of psychedelics and entactogens
Boris D. Heifets, David E. Olson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 104-118
Closed Access | Times Cited: 29

Novel rapid treatment options for adolescent depression
Sandra Ledesma‐Corvi, Jordi Jornet-Plaza, Laura Gálvez‐Melero, et al.
Pharmacological Research (2024) Vol. 201, pp. 107085-107085
Open Access | Times Cited: 9

Proteomic patterns associated with ketamine response in major depressive disorders
Nan Zhou, Xiaolei Shi, Runhua Wang, et al.
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access | Times Cited: 1

Electroacupuncture restores maternal separation-induced glutamatergic presynaptic deficits of the medial prefrontal cortex in adulthood
Xiaorong Zheng, Yuanjia Zheng, Zhe Zhai, et al.
Neuroscience (2025)
Closed Access | Times Cited: 1

Novel insight into astrocyte-mediated gliotransmission modulates the synaptic plasticity in major depressive disorder
Lan Lei, Yufei Wang, Cong-Ya Chen, et al.
Life Sciences (2024) Vol. 355, pp. 122988-122988
Closed Access | Times Cited: 7

ER stress in mouse serotonin neurons triggers a depressive phenotype alleviated by ketamine targeting eIF2α signaling
Lluís Miquel-Rio, Unai Sarriés-Serrano, María Sancho‐Alonso, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109787-109787
Open Access | Times Cited: 6

Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants
Maurizio Fava, Stephen M. Stahl, Luca Pani, et al.
The Journal of Clinical Psychiatry (2024) Vol. 85, Iss. 3
Open Access | Times Cited: 6

Additively manufactured ready-to-use platform using conductive recycled PLA for ketamine sensing
Maria M. C. Souza, Raquel G. Rocha, Gilvana P. Siqueira, et al.
Microchimica Acta (2025) Vol. 192, Iss. 2
Closed Access

Enhancing proteasome activity by NMDAR antagonists explains their therapeutic effect in neurodegenerative and mental diseases
Fikret Şahin, Aslıhan Günel, Buse Türegün Atasoy, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Repeated administration of a subanesthetic dose of ketamine results in impaired motor and cognitive behavior and differential expression of hippocampal P2X1 and P2X7 receptors in adult mice
Teresa Belem Mares-Barbosa, Ares Orlando Cuellar-Santoyo, Victor Manuel Ruiz-Rodríguez, et al.
Behavioural Brain Research (2025), pp. 115441-115441
Closed Access

Ultrasonic vocalisations in the Flinders Sensitive Line rat, a genetic animal model of depression
Linda Marie Kai, Lia P. Iglesias, Kadri Kõiv, et al.
Acta Neuropsychiatrica (2025) Vol. 37
Closed Access

The ketamine chameleon: history, pharmacology, and the contested value of experience
Danny Diep, Sara de la Salle, Julien Thibault Lévesque, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access

A cell type-specific mechanism driving the rapid antidepressant effects of transcranial magnetic stimulation
Michael W. Gongwer, Alex Qi, Alexander S. Enos, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches
Aline Silva de Miranda, Eliana Cristina de Brito Toscano, Venugopal Reddy Venna, et al.
Expert Opinion on Drug Discovery (2025), pp. 1-15
Closed Access

Contrasting patterns of extrasynaptic NMDAR-GluN2B expression in macaque subgenual cingulate and dorsolateral prefrontal cortices
Mary Kate P. Joyce, D. Datta, J.L. Pérez-Arellano, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access

Discovery of a Novel Orally Active Ketamine Derivative with Dual Analgesic and Antidepressant Activities, Lacking Psychomimetic Effects
Syed Muzzammil Masaud, Humaira Nadeem, Babar Murtaza, et al.
ACS Chemical Neuroscience (2025) Vol. 16, Iss. 5, pp. 932-944
Closed Access

Structural basis for channel gating and blockade in tri-heteromeric GluN1-2B-2D NMDA receptor
Hyunook Kang, Max Epstein, Tue G. Banke, et al.
Neuron (2025)
Closed Access

Brain-derived neurotrophic factor (BDNF) changes in rodent models of schizophrenia induced by ketamine: a systematic review
Atefeh Motamedi-Manesh, Mahdieh Farzin Asanjan, Hamed Fallah, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access

Impaired unfolded protein response, BDNF and synuclein markers in postmortem dorsolateral prefrontal cortex and caudate nucleus of patients with depression and Parkinson's disease
Unai Sarriés-Serrano, Lluís Miquel-Rio, Noemí Santana, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025) Vol. 138, pp. 111299-111299
Open Access

Page 1 - Next Page

Scroll to top